Leptospira, the causative agent of leptospirosis, interacts with several host molecules, including extracellular matrix components, coagulation cascade proteins, and human complement regulators. Here we demonstrate that acquisition of factor H (FH) on the Leptospira surface is crucial for bacterial survival in the serum and that these spirochetes, besides interacting with FH, FH related-1, and C4b binding protein (C4BP), also acquire FH like-1 from human serum. We also demonstrate that binding to these complement regulators is mediated by leptospiral immunoglobulin-like (Lig) proteins, previously shown to interact with fibronectin, laminin, collagen, elastin, tropoelastin, and fibrinogen. Factor H binds to Lig proteins via short consensus repeat domains 5 and 20. Competition assays suggest that FH and C4BP have distinct binding sites on Lig proteins. Moreover, FH and C4BP bound to immobilized Ligs display cofactor activity, mediating C3b and C4b degradation by factor I. In conclusion, Lig proteins are multifunctional molecules, contributing to leptospiral adhesion and immune evasion.
Leptospirosis is a worldwide zoonosis and represents a serious health problem in urban areas of tropical developing countries that lack proper sanitation facilities. This neglected infectious disease is caused by spirochetes from the genus Leptospira, which includes pathogenic and saprophytic species [1] . After penetrating the host, successful colonization of target organs by pathogenic Leptospira species is dependent on the bacteria's ability to escape from the host's innate defense mechanisms. The complement system seems to be the major actor in the nonspecific immune response to Leptospira. This is supported by in vitro results demonstrating that saprophytic leptospiral strains are killed within a few minutes in the presence of normal human serum whereas pathogenic strains are able to survive for longer periods of time [2, 3] . Therefore, it is clear that pathogenic leptospires have evolved strategies to evade complement attack.
In order to avoid tissue destruction in the host, the complement system is kept under strict control. Inappropriate activation of complement in the fluid phase is prevented by the regulatory proteins factor H (FH) and C4b binding protein (C4BP), the major negative regulators of the alternative pathway and the classical and lectin pathways, respectively. Factor H, a 150-kDa plasma protein composed of 20 globular domains termed short consensus repeats (SCRs), inhibits the alternative pathway of complement by preventing binding of factor B to C3b, accelerating decay of the C3 convertase C3bBb and acting as a cofactor for the cleavage of C3b by factor I (FI) [4] [5] [6] . C4b binding protein is a 570-kDa plasma glycoprotein composed of 7 identical a-chains and a unique b-chain linked together by a central core [7] [8] [9] . C4b binding protein inhibits the classical and lectin pathways of complement by interfering with the assembly and facilitating the decay of the C3 convertase C4bC2a and acts as a cofactor for FI in the proteolytic inactivation of C4b [9, 10] . One strategy adopted by pathogens to avoid destruction by complement relies on their ability to acquire host fluid-phase regulators, and it has been demonstrated that pathogenic strains of Leptospira bind FH and C4BP for complement evasion [2, 3] . To date, only 2 leptospiral proteins (LenA and LenB) have been shown to interact with FH [11, 12] , and a single leptospiral protein named LcpA has been shown to bind C4BP [13] . Considering that leptospires are highly invasive microorganisms, there may be several other bacterial ligands for these host molecules.
The family of leptospiral immunoglobulin-like (Lig) proteins comprises LigA, LigB, and LigC. These proteins belong to the superfamily of bacterial immunoglobulin-like repeat domain proteins, which includes virulence determinants, such as intimin from enteropathogenic Escherichia coli [14] and invasin from Yersinia pseudotuberculosis [15] . The N-terminal 630 amino acid sequences of LigA and LigB are identical, but the C-terminal amino acid sequences are variable with approximately 34% of identities. LigB also has a C-terminal, nonrepeat domain of 771 amino acid residues; ligC is a pseudogene in Leptospira interrogans serovar Copenhageni and Leptospira kirshneri serovar Grippotyphosa [16] [17] [18] .
The lig genes are present in pathogenic but not saprophytic Leptospira species. The expression of Lig proteins is closely associated with host infection because they are expressed in virulent strains but not in culture-attenuated leptospires. Furthermore, Lig proteins are able to induce antibody responses in patients and infected animals [16, 17, 19] . Their expression is controlled by osmolarity, a key environmental signal that enhances binding of Leptospira to host cells [20, 21] . They have been identified as extracellular matrix-binding proteins because they are able to interact with fibronectin, laminin, collagen, fibrinogen, elastin, and tropoelastin [22] [23] [24] [25] [26] [27] [28] [29] . Because important virulence factors of many pathogens may interact with multiple host proteins, including coagulation cascade molecules, extracellular matrix components, and complement regulators, during infection, we decided to evaluate whether the Lig proteins would contribute to leptospiral immune evasion by interacting with host complement regulators.
MATERIALS AND METHODS

Bacterial Strains and Plasmids
Pathogenic L. interrogans serovar Pomona strain Fromm was cultured at 29°C under aerobic conditions as previously described [30] . Escherichia coli DH5a was used as the cloning host strain and E. coli BL21 (DE3) was used as the host strain for the expression of the recombinant proteins, using the T7 promoter-based expression plasmid pAE [31] .
Sera, Purified Proteins, and Antibodies
Normal human sera (NHS) were obtained from healthy donors. The sera were pooled and stored at 280°C. Human FH, FHdepleted human serum (FH-depl), C4BP, C3b, C4b, and FI were purchased from Complement Technology. Rabbit antihuman FH was a gift from Dr Sánchez-Corral (University Hospital La Paz, Madrid, Spain), goat antihuman FH was purchased from Quidel, and rabbit antihuman C4BP was purchased from Calbiochem. Goat antihuman C3 polyclonal antibody was purchased from Complement Technology, mouse anti-human C4d monoclonal antibody was purchased from Quidel, and secondary peroxidase-conjugated antibodies were purchased from Sigma-Aldrich. The antihuman FH monoclonal antibodies 131X [32] and A229 were obtained from Quidel, C18 [33] was obtained from Enzo Life Sciences, and OX24 [32] was obtained from Santa Cruz Biotechnology. Codon-optimized FH deletion mutants comprising SCRs 1-4, SCRs 8-14, and SCRs 15-20, as well as FH like-1 (FHL-1) and FH related-1 (FHR-1) proteins, were synthetized (GenScript), cloned into the pBSV-8His vector, expressed in insect cells, and purified as described [34] .
Cloning, Expression, and Purification of Lig Fragments in E. coli
The coding sequences of LigAC (nucleotides 1891-3675), LigBN (nucleotides 76-1890), and LigBC (nucleotides 1891-3468) were amplified by polymerase chain reaction from genomic DNA of L. interrogans strain 10A using the following primers: LigAC, F: CTCGAGCTTACCGTTTCCAACACAAAC/ R:CCATGGTTATGGCTCCGTTTTAATAGAG; LigBN, F: CCTCGAGGGTCTGGTAGGATTAAC/R:CCATGGCTAAATAT CCGTATTAGAGG; LigBC, F: CTCGAGGCTGAAATTAAAAA TACC/R:GAAGCTTTTAGGATAAATCAAGGG. Cloning, expression, and purification of recombinant proteins with an amino-terminal 6xHis tag were performed as previously described [13] .
Serum Susceptibility Assay
Leptospires were grown to late log phase and washed twice with phosphate-buffered saline (PBS). Bacteria (1.0 3 10 8 ) were incubated at 37°C for 120 minutes with 40% of FH-depl or with 40% of FH-depl reconstituted with purified FH (50-500 lg/mL). Bacterial survival was assessed by counting viable organisms using dark field microscopy and a PetroffHausser chamber. Three independent experiments were performed. For statistical analyses, survival in each condition was compared with survival in FH-depl by using the Student 2-tailed t test.
Interaction of L. interrogans with FH, FHL-1, and FHR-1
Freshly harvested leptospires (1.0 3 10 9 ) were washed with PBS and then incubated with 2 lg of purified FH, recombinant FHL-1 (rFHL-1), or recombinant FHR-1 (rFHR-1) for 60 minutes at 37°C with agitation. After washing, whole cell lysates were subjected to 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) under nonreducing conditions and transferred to a nitrocellulose membrane [13] , which was incubated with a polyclonal antihuman FH (1:10 000), followed by a peroxidase-conjugated antigoat immunoglobulin G (IgG) (1:10000). Positive signals were detected by enhanced chemiluminescence (West Pico, Pierce).
Protein Interaction Assays
For ligand affinity blotting, recombinant proteins were subjected to 10% SDS-PAGE under nonreducing conditions and transferred to nitrocellulose membranes [13] . The membranes were incubated for 90 minutes with 10% NHS as a source of FH or with purified C4BP (100 lg) diluted in PBS-Tween (0.05%). After washing, the membranes were incubated with polyclonal rabbit antibodies recognizing either human FH or C4BP (1:5000), followed by peroxidase-conjugated secondary antibodies (1:5000). Positive signals were detected by enhanced chemiluminescence (West Pico, Pierce).
For enzyme-linked immunosorbent assay (ELISA), microtiter plates were coated with LigAC, LigBC, LigBN, or the negative control protein encoded by LIC10301 or bovine serum albumin (BSA) (100 lL or 10 lg/mL, respectively) overnight at 4°C. The wells were washed with PBS, blocked with PBS-1% BSA for 2 hours at 37°C, and incubated with purified FH or C4BP (100 lL or 0-50 lg/mL, respectively) for 60 minutes at room temperature (RT). After washing with PBS, bound proteins were detected with rabbit antihuman FH or rabbit antihuman C4BP (1:5000), followed by peroxidase-conjugated antirabbit IgG (1:5000). Substrate reaction was performed with o-phenylenediamine dihydrochloride (Pierce), and absorbance was measured at 492 nm.
Competition of FH and C4BP binding to immobilized Lig proteins was assessed by ELISA. Wells were coated with the recombinant proteins and blocked as described above. One microgram of FH mixed with different amounts of C4BP (different molar ratios) was added to each well, and the bound proteins were detected with either rabbit antihuman FH or rabbit antihuman C4BP.
Localization of binding regions within FH was also achieved using an ELISA-based assay. Lig proteins were immobilized as described above and, after blocking, incubated with 2 lg of rFHL-1, rFHR-1, SCRs 1-4 (N-terminal region of FH), SCRs 8-14 (central region of FH), and SCRs 15-20 construct (C-terminal region of FH). Intact purified FH was included as a control. Bound proteins were detected with goat antihuman FH, which reacted similarly with all constructs.
Inhibition assays were performed by preincubating purified FH (1 lg) for 30 minutes at RT with monoclonal antibodies directed against different regions of FH (1 lg each). Factor H was then allowed to interact with immobilized LigBC and was detected with goat antihuman FH (1:10 000).
Cofactor Activity Assay
Cofactor activity of FH or C4BP bound to LigAC, LigBC, LigBN, and rLIC10301 (negative control) was analyzed by measuring FI-mediated cleavage of C3b (FH as a cofactor) or C4b (C4BP as a cofactor). Microtiter plate wells were coated with 1 lg of each recombinant protein diluted in PBS for 16 hours at 4°C. After blocking with 3% BSA, 2 lg of FH or C4BP or 5% NHS was added to each well for 60 minutes at 37°C. After washing with PBS, C3b or C4b, both 500 ng per assay, and FI at 250 ng per reaction were added to the wells and incubated for up to 240 minutes at 37°C. Reaction mixtures were subjected to Western blotting, and cleavage fragments of C3b and C4b were detected with goat antihuman C3 polyclonal antibodies (1:10 000) or with a mouse antihuman C4d monoclonal antibody (1:1000), followed by incubation with secondary peroxidase-conjugated antibodies. Cofactor activity of FH or FHL-1 bound to intact L. interrogans strain Fromm was assessed as previously described [13] .
RESULTS
Acquisition of FH contributes to Leptospira Survival
Acquisition of host FH as a strategy for leptospiral complement evasion has been previously described [2] . Surface-bound FH retains cofactor activity in the cleavage of C3b by FI, indicating that acquisition of this complement regulator may contribute to leptospiral serum resistance [2] . To further assess the protective role of acquired FH, L. interrogans serovar Pomona strain Fromm, previously shown to resist human complement [3] , was incubated in FH-depl and in the same serum reconstituted with purified FH up to 500 lg/mL (FH physiological concentration: 443 6 106 [35] ). Addition of FH to the depleted serum significantly increased bacterial survival in a dose-dependent manner ( Figure 1 ).
Pathogenic Leptospira Bind FH, FHL-1, and FHR-1
Previous data demonstrated that pathogenic Leptospira bind FH and, most probably, FHR-1a/b from human serum [2] . In this study, we used rFHL-1 and rFHR-1 to more precisely ascertain which FH family proteins interact with Leptospira. Bacteria were incubated with purified FH or with the recombinant proteins mentioned above, and whole cell lysates were subjected to Western blotting with anti-FH. Bands corresponding to FH (155 kDa), rFHL-1 (43 kDa), and rFHR-1 (42 kDa) were detected, thus showing that pathogenic Leptospira bind at least these 3 members of the FH protein family (Figure 2A ). Cofactor activity of bacterial surface-attached FH and rFHL-1 was assayed by measuring FI-mediated cleavage of C3b. As expected, FI cleaved C3b a' chain (110 kDa) in the presence of FH and rFHL-1, generating cleavage products ranging from 28 to 43 kDa ( Figure 2B ). Cleavage was much more efficient in the presence of FH, as indicated by the complete disappearance of the 110 kDa C3b á chain. Interestingly, 1 or more bacterial compounds may act as FI cofactor(s) because similar C3b cleavage profiles were observed in the presence of FHL-1 or in the absence of any cofactor added ( Figure 2B ). Another possibility is that protease(s) on the surface of, or secreted by, pathogenic Leptospira may also contribute to C3b cleavage (Fraga TR, Vasconcellos SA, Barbosa AS, Isaac L, unpublished data).
Lig Proteins Interact With the Complement Regulators FH and C4BP
Considering that Lig proteins are multifunctional molecules capable of interacting with various host proteins, we decided to evaluate whether they would contribute to leptospiral immune evasion by binding human complement regulators. Because LigA and LigB share 100% sequence identity at their N-terminus but vary at their C-terminus, 3 fragments were produced and purified: LigAC, LigBC, and LigBN (corresponding to the shared N-terminal region of both proteins) ( Figure 3A) . SDS-PAGE gels of the purified recombinant proteins are shown in Figure 3B . Ligand affinity blotting and ELISA were used to assess binding of Lig proteins to FH and C4BP. Both complement regulators bound to the N-terminus and the C-terminus of the Lig proteins ( Figure 4A ). LcpA, a leptospiral protein previously shown to interact with C4BP [13] , was included as a positive control ( Figure 4A ). In ELISA assays, a dose-dependent binding of LigAC, LigBC, and LigBN to purified FH and C4BP was observed ( Figure 4B) . No binding to FH or C4BP was detected with BSA or with rLIC10301 (negative controls) ( Figure 4A and 4B) . From these results, we conclude that Lig proteins interact with FH and C4BP through at least 2 different binding sites, 1 located within the N-terminal domain and the other within the C-terminal domain.
FH and C4BP Retain Cofactor Activity When Bound to LigA and LigB
To assess the functional activity of FH and C4BP upon binding to Lig proteins, LigAC, LigBC, LigBN, and rLIC10301 (negative control) were immobilized and incubated with NHS, purified FH or purified C4BP. After washing, C3b or C4b and FI were added. The cleavage of C3b or C4b was analyzed by Western blotting using antihuman C3 polyclonal or C4d monoclonal antibodies. As depicted in Figure 5 , LigAC, LigBC, and LigBN were able to bind FH and C4BP, which retained their cofactor Figure 1 . Survival of Leptospira interrogans serovar Pomona as a function of increasing concentrations of factor H (FH). The pathogenic L. interrogans strain Fromm was incubated in FH-depleted serum reconstituted with different amounts of purified FH up to physiological concentrations (500 lg/mL). Survival at this concentration was set as 100%. Means 6 SD for 3 independent experiments are shown. * P , .05; ** P , .01.
Figure 2. Interaction of Leptospira interrogans with factor H (FH), FH like-1 (FHL-1), and FH related-1 (FHR-1).
A, The serum-resistant L. interrogans serovar Pomona strain Fromm was incubated with purified FH, recombinant FHL-1 (rFHL-1), recombinant FHR-1 (rFHR-1), or buffer. Whole cell lysates were subjected to Western blotting with anti-FH. Bands corresponding to FH (155 kDa), rFHL-1 (43 kDa), and rFHR-1 (42 kDa) were detected. P, bacterial pellets; W, aliquots of the last wash. B, L. interrogans serovar Pomona strain Fromm (LPF) was incubated with 2 lg of purified FH or rFHL-1 as well as in the absence of any cofactor. After extensive washing, C3b and factor I (FI) were added. Incubation proceeded for 2 h and the bacteria were pelleted by centrifugation. Samples from supernatants were subjected to reducing sodium dodecyl sulfate polyacrylamide gel electrophoresis and analyzed with polyclonal anti-C3 antibodies. C3b cleavage fragments ranging from 28 to 68 kDa are apparent. Control reactions without bacteria are shown to the left.
activities. When the proteins were incubated with serum or FH, the C3b cleavage products a'68, a'46, and a'43 were produced. Furthermore, when the Lig protein fragments were incubated with serum or C4BP, a 45-kDa band corresponding to C4d could be detected. Cleavage of C4b was much more efficient when Lig proteins were incubated with purified C4BP than when incubated with serum. It is possible that C4BP binding to Ligs may be hampered in the presence of other serum proteins. No C3b or C4b cleavage was observed when rLIC10301was incubated with FH or C4BP ( Figure 5 ).
FH and C4BP Do Not Share Binding Sites for the Lig Proteins
We next analyzed whether FH and C4BP compete for the same binding sites on Lig proteins. LigAC, LigBC, and LigBN were immobilized in microtiter wells, and competitive binding assays were performed with increasing amounts of C4BP in the presence of a constant amount (1 lg) of FH, resulting in different FH:C4BP molar ratios. The wells were probed with either anti-FH or anti-C4BP. As shown in Figure 6 , C4BP did not compete with FH for binding to Lig proteins even at molar ratios beyond that observed in physiological conditions (1 FH: 0.125 C4BP). Similar results were observed when 5 lg of FH were used to compete with different concentrations of C4BP. We also obtained equivalent results when 5 lg of C4BP were used to compete with different concentrations of FH (data not shown). We therefore conclude that FH and C4BP do not seem to have overlapping binding sites on Lig proteins. A, Purified recombinant proteins LigAC, LigBC, and LigBN were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. The membranes were incubated with 10% normal human sera (as a source of FH) or with purified C4BP. Factor H and C4BP were detected with specific antibodies by Western blot. Bovine serum albumin and rLIC10301 were included as negative controls, and LcpA was included as a positive control for C4BP binding [13] . B, Microtiter plates were coated with 1 lg of recombinant proteins, and different amounts of purified FH or C4BP (0-5 lg) were added to each well. BSA and rLIC10301 were included as negative controls. Binding was detected with specific antibodies. Each point represents the mean absorbance value at 492 nm 6 the SD of 3 independent experiments, each performed in duplicate. Binding of FH or C4BP to the recombinant proteins was compared with the binding of these molecules to BSA by the 2-tailed t test (* P , .05).
Lig Proteins Interact With FH, FHL-1, and FHR-1
To map the binding sites within FH that interact with Lig proteins, the latter were immobilized and incubated with fulllength FH, rFHL-1, rFHR-1, or the FH fragments SCRs 1-4, SCRs 8-14, and SCRs 15-20. Factor H, rFHL-1, rFHR-1, and SCRs 15-20 interacted with the N-terminus as well as with the C-terminus of LigA and LigB, whereas SCRs 8-14 did not bind to any of these proteins. These results suggest that the central region of FH is not involved in the binding to Lig proteins. Lig proteins showed a strong binding to the SCRs 15-20 construct, and binding to FHR-1 was even more prominent, suggesting the involvement of both FH SCRs 6-7 and SCRs 18-20 and the corresponding FHR-1 domains in the interaction ( Figure 7A ). Contrary to LigAC and LigBN, LigBC seems to harbor an additional binding site within SCR 1-4 ( Figure 7A ). Monoclonal antibodies directed against SCR 5 and SCR 20 inhibited binding of FH to LigBC by approximately 50%, thus confirming that these particular domains are involved in the interaction of FH with the C-terminal portion of LigB ( Figure 7B ). Similar inhibitory profiles using the same antibodies were observed with LigAC and LigBN (data not shown). A summary of the FH SCR domains that possibly interact with LigA and LigB is presented in Figure 7C .
DISCUSSION
In this work, we demonstrated that acquisition of FH by pathogenic Leptospira has a protective role, being crucial for (1 lg) were immobilized on microtiter plates and incubated with 5% normal human sera or with purified FH or C4BP (2 lg). Control reactions in which FH or C4BP were omitted were also performed. After washing, C3b or C4b and factor I (FI) were added. The reactions were incubated for 1, 2, and 4 h at 37°C. The products were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis, and the cleavage fragments of C3b or C4b were detected by Western blotting with antihuman C3 polyclonal or C4d monoclonal antibodies. The presence of bands at 43, 46, and 68 kDa indicates that acquired FH was able to promote FI-mediated cleavage of C3b. The presence of a 45-kDa fragment corresponding to C4d indicates that acquired C4BP was able to promote FI-mediated cleavage of C4b (anti-C4d monoclonal antibody recognizes both the intact a' chain of C4b and its cleaved product C4d). rLIC10301 was used as a negative control because this protein does not bind FH or C4BP. *, fragment resulting from partial cleavage of C4b.
bacterial survival. We also showed that in addition to interacting with FH, leptospires bind FHL-1 and FHR-1. FHL-1 binding does not seem to be of great relevance for this particular spirochete because similar C3b cleavage profiles were observed in the presence or in the absence of this cofactor ( Figure 2B ). However, acquisition of FHR-1 may be advantageous due to its regulatory function at the level of C5 [37] . FHR-1 was shown to inhibit C5 convertase activity and to interfere with C5b surface deposition and terminal complex formation. This activity may be beneficial to a number of bacterial and fungal pathogens ( [11, [38] [39] [40] [41] [42] , this study) which, in addition to interacting with FH, also bind FHR-1, allowing control of complement activation at early and late steps of the cascade.
Pathogen-bound FH family proteins can also mediate adhesion and facilitate the invasion of host cells [43, 44] . On the other hand, the binding of FHR-1 to the pathogen surface may be of advantage to the host for 2 reasons: (1) FHR-1 can compete with FH due to overlapping binding sites and thus reduce complement control at the surface of the pathogen [39] , and (2) both FHR-1 and FH may mediate adhesion and enhance antimicrobial activity of host immune cells, as shown for the interaction of Candida albicans with human neutrophils [45] .
Another interesting point that came out of this study was the finding that L. interrogans has both acquired and endogenous complement regulatory activity with regard to C3b degradation ( Figure 2B ). Studies to identify bacterial surface components with cofactor or protease activity are under way. C3b cleavage in the presence of FH is much more efficient, as illustrated by the complete disappearance of its 110 kDa a' chain and the accentuated generation of cleavage products ranging from 28 to 43 kDa ( Figure 2B ). Nevertheless, endogenous activity may confer additional survival advantage in the host by contributing to pathogenic Leptospira's ability to control complement activation.
Lig proteins are important virulence factors because loss of their expression correlates with loss of virulence during culture attenuation. Moreover, they are upregulated during host infection [16, 18, 20, 46] . These proteins interact with a diverse array of host molecules, including proteins of the extracellular matrix and the coagulation cascade [22] [23] [24] [25] [26] [27] [28] [29] . Their functional plurality prompted us to investigate whether they would interact Figure 6 . Factor H (FH) and C4b binding protein (C4BP) do not share binding sites for leptospiral immunoglobulin-like (Lig) proteins. Competition inhibition assays were performed in which different amounts of C4BP (0-40 lg/mL) and a constant amount of FH (10 lg/mL) were added to immobilized LigAC, LigBC, and LigBN. Factor H:C4BP molar ratios are indicated below the graphs. Bound FH and C4BP were detected using goat antihuman FH (black boxes) and rabbit antihuman C4BP antibodies (gray boxes), respectively, followed by peroxidase-conjugated secondary antibodies. Optical densities were determined at 492 nm. Data represent the mean 6 SD of 3 independent experiments, each performed in duplicate.
with host complement regulators as well. Our results demonstrate that LigA and LigB bind FH and C4BP from human serum and as purified proteins in a dose-dependent manner. We showed that both the N-and the C-terminus of these proteins harbor binding sites for FH and C4BP. Importantly, both complement regulators are capable of acting as cofactors when bound to the Ligs, as indicated by the presence of C3b and C4d cleavage fragments after incubation with FI. Our data indicate that C4BP does not inhibit the interaction between FH and LigAC, LigBC, or LigBN ( Figure 6 ) and vice versa (data not shown), even at FH:C4BP molar ratios beyond those found in the plasma (1 FH:0.125 C4BP). Thus the 2 complement regulators can bind simultaneously. Cleavage of C4b was much more efficient in the presence of purified C4BP compared with the cleavage observed with NHS. This suggests that other serum proteins could compete with C4BP for the same binding sites on the Lig proteins.
In addition to interacting with FH and C4BP, Lig proteins also bind FHL-1 and FHR-1 ( Figure 7A ). In an attempt to map the FH domains that interact with the Ligs, recombinant constructs encompassing different FH SCRs and antibodies directed against specific SCRs were used. As for the majority of bacterial proteins described to date (reviewed in [36] ), Lig proteins probably interact with FH through SCRs 5-7 and also through carboxy-terminal SCRs 18-20 ( Figure 7) .
Lig proteins interact with numerous host molecules, notably proteins that mediate attachment to host tissues [22] [23] [24] [25] [26] [27] [28] [29] . In this work, we show that these multifunctional leptospiral proteins also bind complement regulators. The ability to adhere to host cells and to the extracellular matrix as well as the capacity to escape complement are 2 fundamental activities that greatly contribute to successful colonization of the host. Interestingly, Lig proteins have been shown to be the most promising vaccine candidates against leptospirosis, conferring protective immunity against lethal infection in the hamster model of the disease [47] [48] [49] [50] . One possible explanation for the usefulness of Lig proteins as vaccine antigens is that Lig-specific antibodies might be able to block binding of complement regulators and extracellular matrix molecules to the bacterial surface, thereby enhancing leptospiral susceptibility to complement-mediated killing.
Notes
